Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
Nature Immunology
|
February 5, 2025
Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation
Stanislav Dikiy, Aazam P Ghelani, Andrew G Levine, et al.
Cancer Research
|
June 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones
Mariam Mathew George, Linda Hamadene, Yacine Marouf, et al.
Nature Communications
|
March 25, 2025
Author Correction: Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
Alexander Solovyov, Julie M Behr, David Hoyos, et al.
Nature Communications
|
February 28, 2025
Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
Alexander Solovyov, Julie M Behr, David Hoyos, et al.
Ebiomedicine
|
December 10, 2025
Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome
Emilie Montellier, Olivier Manches, Jonathan Gaucher, et al.
JCI Insight
|
February 15, 2017
Diverse repetitive element RNA expression defines epigenetic and immunologic features of colon cancer
Niyati Desai, Dipti Sajed, Kshitij S Arora, et al.
Cancer Discovery
|
February 7, 2025
LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Eunae You, Bidish K Patel, Alexandra S Rojas, et al.
Cell Genomics
|
September 25, 2025
Repeats mimic pathogen-associated patterns across a vast evolutionary landscape
Petr Šulc, Andrea Di Gioacchino, Alexander Solovyov, et al.
Iscience
|
July 5, 2022
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1
Nicolas Vabret, Valérie Najburg, Alexander Solovyov, et al.
Biorxiv : the Preprint Server for Biology
|
April 15, 2024
Distinct genomic and immunologic tumor evolution in germline <i>TP53</i>-driven breast cancers
Nabamita Boruah, David Hoyos, Renyta Moses, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
Nature Immunology
|
February 5, 2025
Terminal differentiation and persistence of effector regulatory T cells essential for preventing intestinal inflammation
Stanislav Dikiy, Aazam P Ghelani, Andrew G Levine, et al.
Cancer Research
|
June 22, 2026
Immune checkpoint blockade augments lymphodepleting chemotherapy-induced antitumor immunity by expanding effector CD8+ T cell clones
Mariam Mathew George, Linda Hamadene, Yacine Marouf, et al.
Nature Communications
|
March 25, 2025
Author Correction: Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
Alexander Solovyov, Julie M Behr, David Hoyos, et al.
Nature Communications
|
February 28, 2025
Pan-cancer multi-omic model of LINE-1 activity reveals locus heterogeneity of retrotransposition efficiency
Alexander Solovyov, Julie M Behr, David Hoyos, et al.
Ebiomedicine
|
December 10, 2025
Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome
Emilie Montellier, Olivier Manches, Jonathan Gaucher, et al.
JCI Insight
|
February 15, 2017
Diverse repetitive element RNA expression defines epigenetic and immunologic features of colon cancer
Niyati Desai, Dipti Sajed, Kshitij S Arora, et al.
Cancer Discovery
|
February 7, 2025
LINE-1 ORF1p Mimics Viral Innate Immune Evasion Mechanisms in Pancreatic Ductal Adenocarcinoma
Eunae You, Bidish K Patel, Alexandra S Rojas, et al.
Cell Genomics
|
September 25, 2025
Repeats mimic pathogen-associated patterns across a vast evolutionary landscape
Petr Šulc, Andrea Di Gioacchino, Alexander Solovyov, et al.
Iscience
|
July 5, 2022
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1
Nicolas Vabret, Valérie Najburg, Alexander Solovyov, et al.
Biorxiv : the Preprint Server for Biology
|
April 15, 2024
Distinct genomic and immunologic tumor evolution in germline <i>TP53</i>-driven breast cancers
Nabamita Boruah, David Hoyos, Renyta Moses, et al.
Page
of 9